These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16162450)

  • 21. [Botulinum toxin and traumatic brain injury].
    Duprey E; Dehail P; Cuny E; Arné P; Fernandez B; Joseph PA; Mazaux JM; Barat M
    Ann Readapt Med Phys; 2003 Jul; 46(6):303-6. PubMed ID: 12928134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of botulinum neurotoxin for spasticity].
    Mukai Y; Kaji R
    Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spasticity. Physical therapy, preventive measures and treatment].
    Gay S; Egon G
    Ann Fr Anesth Reanim; 2005 Jun; 24(6):663-6. PubMed ID: 15950113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relearning of locomotion in injured spinal cord: new directions for rehabilitation programs.
    Krishnan RV
    Int J Neurosci; 2003 Oct; 113(10):1333-51. PubMed ID: 14534034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal cord injury and use of botulinum toxin in reducing spasticity.
    Fried GW; Fried KM
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):901-10. PubMed ID: 14580044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Botulinum toxins for pain].
    Soinila S; Haanpää M
    Duodecim; 2011; 127(22):2425-30. PubMed ID: 22238920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injectable neuromodulatory agents: botulinum toxin therapy.
    Frenkl TL; Rackley RR
    Urol Clin North Am; 2005 Feb; 32(1):89-99. PubMed ID: 15698881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological effects of botulinum toxin in spasticity.
    Gracies JM
    Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Guidelines for the treatment of child spasticity using botulinum toxin].
    Pascual-Pascual SI; Herrera-Galante A; Póo P; García-Aymerich V; Aguilar-Barberà M; Bori-Fortuny I; García-Ruiz PJ; Garreta-Figuera R; Lanzas-Melendo G; de Miguel-León I; Miquel-Rodríguez F; Vivancos-Matellano F;
    Rev Neurol; 2007 Mar 1-15; 44(5):303-9. PubMed ID: 17342682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current clinical applications of botulinum toxin.
    Truong DD; Stenner A; Reichel G
    Curr Pharm Des; 2009; 15(31):3671-80. PubMed ID: 19925419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin: historical perspective and potential new indications.
    Jankovic J; Brin MF
    Muscle Nerve Suppl; 1997; 6():S129-45. PubMed ID: 9826986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity.
    Albany K
    Muscle Nerve Suppl; 1997; 6():S221-31. PubMed ID: 9826993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spasticity treatment with botulinum toxins.
    Ward AB
    J Neural Transm (Vienna); 2008; 115(4):607-16. PubMed ID: 18389166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin in the management of spasticity in adults.
    Turner-Stokes L; Ward A
    Clin Med (Lond); 2002; 2(2):128-30. PubMed ID: 11991094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
    Schnider P; Voller B; Moraru K; Auff E
    Wien Klin Wochenschr; 1999 Oct; 111(20):825-9. PubMed ID: 10586486
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical application of botulinum toxin].
    Grandas F
    Neurologia; 1995; 10(6):224-33. PubMed ID: 7546812
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of spasticity with botulinum toxin].
    Eleopra R; Quatrale R; Tugnoli V
    J Neurosurg Sci; 2003 Mar; 47(1 Suppl 1):68-73. PubMed ID: 14631679
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of botulinum toxin type A and type B for spasticity in upper and lower limbs.
    Bell KR; Williams F
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):821-35. PubMed ID: 14580040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of cellular and synaptic variability in the lamprey spinal cord.
    Parker D; Bevan S
    J Neurophysiol; 2007 Jan; 97(1):44-56. PubMed ID: 17021027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.